PBR:NYSEPetroleo Brasileiro S.A. Petrobras Analysis
Data as of 2026-06-09 - not real-time
$17.75
Latest Price
5/10Risk
Risk Level: Medium
Executive Summary
Petrobras delivered a robust Q1 2026 earnings report, posting record oil production and strong refinery utilization while maintaining disciplined capital spending. The company generated $194.97 billion in operating cash flow and $82.93 billion of free cash flow, underscoring its ability to fund the attractive 9.9% dividend yield. Earnings per share rose to $3.14 and forward EPS is projected at $4.11, reflecting solid profitability. Compared with an industry average P/E of 22.4, the stock trades at a mere 5.65×, highlighting a pronounced valuation gap.
On the technical side, the market price of $17.75 sits below the 20‑day ($19.34) and 50‑day ($20.35) simple moving averages but remains above the 200‑day average ($15.32), indicating a mixed medium‑term bias. The 14‑day RSI of 28.6 places the stock in oversold territory, while the MACD line remains bearish relative to its signal. Current price is hugging a support level near $17.64 with resistance around $20.89, and volume has been trending lower, suggesting limited short‑term buying pressure. Nevertheless, the 30‑day volatility of over 30% and a near‑zero beta point to price swings that are largely independent of broader market moves.
Valuation models reinforce the upside case: the DCF‑derived fair value of $120.6 and analyst median target of $23.3 imply roughly a 28% upside from today’s price. The dividend payout ratio of 41.6% and strong cash generation support the sustainability of the high yield. While leverage is elevated (debt‑to‑equity ≈ 83%), the company’s cash position and cash‑flow coverage mitigate default risk. Taken together, the fundamentals, dividend profile, and upside potential suggest the stock is fundamentally undervalued.
On the technical side, the market price of $17.75 sits below the 20‑day ($19.34) and 50‑day ($20.35) simple moving averages but remains above the 200‑day average ($15.32), indicating a mixed medium‑term bias. The 14‑day RSI of 28.6 places the stock in oversold territory, while the MACD line remains bearish relative to its signal. Current price is hugging a support level near $17.64 with resistance around $20.89, and volume has been trending lower, suggesting limited short‑term buying pressure. Nevertheless, the 30‑day volatility of over 30% and a near‑zero beta point to price swings that are largely independent of broader market moves.
Valuation models reinforce the upside case: the DCF‑derived fair value of $120.6 and analyst median target of $23.3 imply roughly a 28% upside from today’s price. The dividend payout ratio of 41.6% and strong cash generation support the sustainability of the high yield. While leverage is elevated (debt‑to‑equity ≈ 83%), the company’s cash position and cash‑flow coverage mitigate default risk. Taken together, the fundamentals, dividend profile, and upside potential suggest the stock is fundamentally undervalued.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Oversold RSI suggests near‑term bounce
- Price near technical support at $17.64
- Bearish MACD and decreasing volume limit upside
Medium Term
1–3 yearsPositive
Model confidence: 8/10
Key Factors
- Undervalued valuation with ~28% upside
- High dividend yield and sustainable payout
- Strong cash flow and record production support earnings growth
Long Term
> 3 yearsPositive
Model confidence: 9/10
Key Factors
- Diversification into low‑carbon energy positions the company for transition
- Robust dividend provides long‑term income
- Strategic capital discipline and solid balance‑sheet underpins resilience
Key Metrics & Analysis
Financial Health
Revenue Growth0.40%
Profit Margin21.60%
P/E Ratio5.7
ROE25.60%
ROA8.23%
Debt/Equity83.27
P/B Ratio1.4
Op. Cash Flow$195.0B
Free Cash Flow$82.9B
Industry P/E22.4
Technical Analysis
TrendNeutral
RSI28.6
Support$17.64
Resistance$20.89
MA 20$19.34
MA 50$20.35
MA 200$15.32
MACDBearish
VolumeDecreasing
Fear & Greed Index87.64
Valuation
Fair Value$120.59
Target Price$22.82
Upside/Downside28.56%
GradeUndervalued
TypeBlend
Dividend Yield9.90%
Risk Assessment
Beta-0.02
Volatility30.31%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.